Catch up on the top radiology content of the past week.
|Articles|May 1, 2006
DE-MRI depicts postablation scar
Delayed-enhancement MRI creates a clear picture of the atrial scarring produced during pulmonary vein RF ablation, according to researchers at Beth Israel Deaconess Medical Center in Boston.
Advertisement
Delayed-enhancement MRI creates a clear picture of the atrial scarring produced during pulmonary vein RF ablation, according to researchers at Beth Israel Deaconess Medical Center in Boston.
The study of 22 patients found that T1-weighted DE-MRI performed 15 to 30 minutes after gadolinium injection produced distinct differences in contrast between scarred and unscarred tissue around the circumference of the vein.
Contrast-enhanced MRI has been used for nearly six years for preprocedural assessments of pulmonary vein anatomy and PV stenosis. The addition of high resolution DE-MRI helps interventionists judge the potential effectiveness of RF ablation to inhibit atrial fibrillation, said Dana C. Peters, Ph.D., assistant scientific director of the hospital's cardiac MR center. Future research by Peters and cardiac MR section chief Dr. Warren Manning will assess whether fully circumferential anatomic scarring is required for successful RF ablation.
DE-MRI depicts . . .
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Given the increasing prevalence of Alzheimer’s disease and a staggering number of people with dementia who are undiagnosed, this author discusses five essential keys for radiologists and their colleagues to facilitate earlier detection, precision care treatment and monitoring to help ensure timely care and intervention.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Emerging Research Insights and New Advances in Neuroradiology
2
Diagnostic Imaging's Weekly Scan: September 27 — October 3
3
MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5